Skip to main content
Fig. 4 | Cancer Cell International

Fig. 4

From: Emerging trends in the coexistence of primary lung Cancer and hematologic malignancy: a comprehensive analysis of clinicopathological features and genetic abnormalities

Fig. 4

Overall survival (OS) and Progression-free survival (PFS). (A) OS in 85 MPC patients. (B) OS in 27 patients with MPC carrying lung cancer-related gene mutations. (C) OS in 12 advanced patients with lung cancer-associated driver gene mutations. (D) PFS in 11 advanced patients with lung cancer-associated driver gene mutations treated with first-line therapy. A total of 12 patients with advanced lung cancer gene mutations were enrolled, one of whom with an unknown treatment regimen was excluded from PFS analysis

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us